Lyell Immunopharma: Q1 Earnings Snapshot

SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Lyell Immunopharma Inc. (LYEL) on Tuesday reported a loss of $52.2 million in its first quarter.

On a per-share basis, the South San Francisco, California-based company said it had a loss of 18 cents.

The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 19 cents per share.

The biotechnology firm posted revenue of $7,000 in the period.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LYEL at https://www.zacks.com/ap/LYEL